• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

作为食品成分的益生菌物质的监管：上市前批准或“一般认为安全”通知。

Regulation of probiotic substances as ingredients in foods: premarket approval or "generally recognized as safe" notification.

作者信息

Mattia Antonia, Merker Robert

机构信息

Division of Biotechnology and GRAS Notice Review, Office of Food Additive Safety, Center for Food Safety and Applied Nutrition, US Food and Drug Administration, College Park, Maryland 20740, USA.

出版信息

Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S115-8; discussion S144-51. doi: 10.1086/523329.

DOI:10.1086/523329
PMID:18181714
Abstract

This article discusses options and examples of regulations or "generally recognized as safe" determinations that are related to microorganisms in food. A balanced picture of information about the microorganism and its characteristics is needed to make conclusions about its safety.

摘要

本文讨论了与食品中微生物相关的法规选项及示例或“一般认为安全”的判定。要对微生物的安全性得出结论，需要全面了解有关该微生物及其特性的信息。

相似文献

1
Regulation of probiotic substances as ingredients in foods: premarket approval or "generally recognized as safe" notification.作为食品成分的益生菌物质的监管：上市前批准或“一般认为安全”通知。
Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S115-8; discussion S144-51. doi: 10.1086/523329.
2
Health-benefit claims for probiotic products.益生菌产品的健康益处声明。
Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S122-4; discussion S144-51. doi: 10.1086/523327.
3
US Food and Drug Administration regulations governing label claims for food products, including probiotics.美国食品药品监督管理局关于食品（包括益生菌）标签声明的规定。
Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S119-21; discussion S144-51. doi: 10.1086/523328.
4
Current marketplace for probiotics: a Japanese perspective.当前益生菌市场：日本视角
Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S73-5; discussion S144-51. doi: 10.1086/523338.
5
Business considerations in the development of probiotics.益生菌开发中的商业考量。
Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S141-3; discussion S144-51. doi: 10.1086/523323.
6
Probiotics in the United States.美国的益生菌。
Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S67-72; discussion S144-51. doi: 10.1086/523339.
7
The US Food and Drug Administration and probiotics: regulatory categorization.美国食品药品监督管理局与益生菌：监管分类
Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S133-6; discussion S144-51. doi: 10.1086/523324.
8
Allergen-free probiotics.无过敏原益生菌。
J Clin Gastroenterol. 2008 Sep;42 Suppl 3 Pt 2:S201-4. doi: 10.1097/MCG.0b013e31818063ed.
9
Probiotics--the friendly bacteria with market potential in global market.益生菌——在全球市场具有市场潜力的有益细菌。
Pak J Pharm Sci. 2007 Jan;20(1):76-82.
10
Safe and efficacious probiotics: what are they?安全有效的益生菌：它们是什么？
Trends Microbiol. 2006 Aug;14(8):348-52. doi: 10.1016/j.tim.2006.06.006. Epub 2006 Jun 30.

引用本文的文献

1
Inhibition of infection-associated oral bacteria adhesion by probiotics: and models.益生菌对感染相关口腔细菌黏附的抑制作用：以及模型。
iScience. 2025 Apr 11;28(5):112412. doi: 10.1016/j.isci.2025.112412. eCollection 2025 May 16.
2
YNH inhibits proliferation of HeLa cells and promotes their apoptosis by modulating the PI3K/AKT pathway.YNH通过调节PI3K/AKT信号通路抑制HeLa细胞的增殖并促进其凋亡。
Contemp Oncol (Pozn). 2025;29(1):55-68. doi: 10.5114/wo.2025.148642. Epub 2025 Mar 18.
3
Restriction of growth and biofilm formation of pathogens by caprine gut-derived probiotic bacteria.
山羊肠道源益生菌对病原体生长和生物膜形成的抑制作用
Front Microbiol. 2024 Jul 29;15:1428808. doi: 10.3389/fmicb.2024.1428808. eCollection 2024.
4
Characterization of feline-originated probiotics Lactobacillus rhamnosus CACC612 and Bifidobacterium animalis subsp. lactis CACC789 and and evaluation of their host response.猫源益生菌鼠李糖乳杆菌 CACC612 和动物双歧杆菌亚种 lactis CACC789 的特性及其宿主反应的评价。
BMC Vet Res. 2024 Apr 1;20(1):128. doi: 10.1186/s12917-024-03975-3.
5
Comparing technology and regulatory landscape of probiotics as food, dietary supplements and live biotherapeutics.比较益生菌作为食品、膳食补充剂和活体生物治疗剂的技术与监管环境。
Front Microbiol. 2023 Dec 19;14:1272754. doi: 10.3389/fmicb.2023.1272754. eCollection 2023.
6
The Effects of Bifidobacterium Probiotic Supplementation on Blood Glucose: A Systematic Review and Meta-Analysis of Animal Models and Clinical Evidence.双歧杆菌益生菌补充剂对血糖的影响：动物模型和临床证据的系统评价和荟萃分析。
Adv Nutr. 2024 Jan;15(1):100137. doi: 10.1016/j.advnut.2023.10.009. Epub 2023 Nov 2.
7
The Use of Probiotics for Management and Improvement of Reproductive Eubiosis and Function.益生菌在生殖生态和功能的管理及改善中的应用。
Nutrients. 2022 Feb 21;14(4):902. doi: 10.3390/nu14040902.
8
Efficacy of Probiotics as Prophylaxis for Urinary Tract Infections in Premenopausal Women: A Systematic Review and Meta-Analysis.益生菌对绝经前女性尿路感染的预防作用：一项系统评价与荟萃分析
Cureus. 2021 Oct 17;13(10):e18843. doi: 10.7759/cureus.18843. eCollection 2021 Oct.
9
Probiotics and Prebiotics as a Strategy for Non-Alcoholic Fatty Liver Disease, a Narrative Review.益生菌和益生元作为非酒精性脂肪性肝病的一种治疗策略：一篇叙述性综述
Foods. 2021 Jul 25;10(8):1719. doi: 10.3390/foods10081719.
10
Spotlight on the Compositional Quality of Probiotic Formulations Marketed Worldwide.全球益生菌制剂产品成分质量聚焦
Front Microbiol. 2021 Jul 20;12:693973. doi: 10.3389/fmicb.2021.693973. eCollection 2021.